15440 LAGUNA CANYON ROAD, IRVINE, CA
Earnings Release
Investor Presentation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Material Contracts, Unregistered Sales of Equity Securities, Other Events
Tarsus Pharmaceuticals, Inc. Annual Meeting Results - June 25, 2026
Reports First Quarter 2026 Financial Results and Recent Business Achievements
Annual Report to Security Holders
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload